Long-term follow-up of cytokines and soluble cytokine receptors in peripheral blood of patients with juvenile rheumatoid arthritis

Journal of Interferon and Cytokine Research

Volumn 19, Issue 9, 1999, Pages 1005-1010

  Mangge, Harald ^a,b   Gallistl, Siegfried ^a   Schauenstein, Konrad ^a  

^a UNIVERSITY OF GRAZ   (Austria)

^b Universitatsklinik fur Kinder und Jugendheilkunde Graz   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; CYTOKINE RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 8; PROTEIN KINASE P60; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADOLESCENT; ARTICLE; BLOOD LEVEL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE CLASSIFICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; LONG TERM CARE; MALE; PRIORITY JOURNAL; SYSTEMIC DISEASE;

ADOLESCENT; ARTHRITIS, RHEUMATOID; CHILD; CHILD, PRESCHOOL; CYTOKINES; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PROGNOSIS; RECEPTORS, CYTOKINE; SOLUBILITY;

EID: 0032827355     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999099313217     Document Type: Article

References (34)

1. SOUTHWOOD, T., and WOO, P. (1995). Juvenile chronic arthritis. Baillieres Clin. Rheumatol. 9, 331-353.
2. PRIEUR, A. (1994). Chronic arthritis in children. Curr. Opin. Rheumatol. 6, 513-517.
3. THOMPSON, S., GROM, A., BAILEY, S., LUYRINK, L., GIANNINI, E., MURRAY, K., PASSO, M., LOVELL, D., CHOI, E., and GLASS, D. (1995). Patterns of T lymphocyte clonal expansion in HLA-typed patients with juvenile rheumatoid arthritis. J. Rheumatol. 22, 1356-1364.
4. DUFF, G. (1993). Cytokines and anti-cytokines. Br. J. Rheumatol. 32(Suppl. 1), 15-20.
5. ALTOMONTE, L., ZOLI, A., MIRONE, L., SCOLIERI, P., and MAGARO, M. (1992). Serum levels of interleukin-1β, tumor necrosis factor-α and interleukin-2 in rheumatoid arthritis. Correlation with disease activity. Clin. Rheumatol. 11, 202-205.
6. WOLF, R., BRELSFORD, W., HALL, V., and ADAMS, S. (1992). Cytokines and soluble interleukin 2 receptors in rheumatoid arthritis. J. Rheumatol. 19, 524-528.
7. TEBIB, J., BOUGHABA, H., LETROUBLON, M., BIENVENUE, J., NOEL, E., ARMANET, P., COLSON, F., ROULLET A., and BOUVIER M. (1991). Serum IL-2 level in rheumatoid arthritis correlation with joint destruction and disease progression. Eur. Cytokine Netw. 2, 239-243.
8. RIDDERSTAD, A., ABEDI-VALUGERDI, M., and MOLLER, E. (1991). Cytokines in rheumatoid arthritis. Ann. Med. 23, 219-223.
9. HOLT, I., COOPER, R., DENTON, J., MEAGER, A., and HOPKINS, S. (1992). Cytokine interrelationships and their association with disease activity in arthritis. Br. J. Rheumatol. 31, 725-733.
10. COPE, A., ADERKA, D., DOHERTY, M., ENGELMANN, H., GIBBONS, D., JONES, A., BRENNAN, F., MAINI, R., WALLACH, D., and FELDMANN, M. (1992). Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases. Arthritis Rheum. 35, 1160-1169.
11. MANICOURT, D., TRIKI, R., FUKUDA, K., DEVOGELAER, J., NAGANT DE DEUXCHAISNES, C., and THONAR, E. (1993). Levels of circulating tumor necrosis factor alpha and interleukin-6 in patients with rheumatoid arthritis. Relationship to serum levels of hyaluronan and antigenic keratan sulfate. Arthritis Rheum. 36, 490-499.
12. SAXNE, T., PALLADINO, M., HEINEGAARD, D., TALAL, N., and WOLLHEIM, F. (1988). Detection of tumor necrosis factor α but not tumor necrosis factor β in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum. 31, 1041-1045.
13. HOUSSIAU, F., DEVOGELAER, J., VAN DAMME, J., NAGANT DE DEUXCHAISNES, C., and VAN SNICK, J. (1988). Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum. 31, 784-788.
14. BRENNAN, F., and FELDMAN, M. (1992). Cytokines in autoimmunity. Curr. Opin. Immunol. 4, 754-759.
15. WENDLING, D., RACADOT, E., VIEL, J., and MERCIER, M. (1992). Soluble interleukin-2 receptor is unhelpful in chronic inflammatory rheumatism. Pathol. Biol. Paris 40, 895-898.
16. HARRINGTON, L., AFFLECK, G., URROWS, S., TENNEN, H., HIGGINS, P., ZAUTRA, A., and HUFFMAN, S. (1993). Temporal covariation of soluble interleukin-2 receptor levels, daily stress, and disease activity in rheumatoid arthritis. Arthritis Rheum. 36, 199-203.
17. ROUX-LOMBARD, P., PUNZI, L., HASLER, F., BAS, S., TODESCO. S., GALLATI, H., GUERNE, P., and DAYER, J. (1993). Soluble tumor necrosis factor receptors in human inflammatory synovial fluids. Arthritis Rheum. 36, 485-189.
18. MADSON, K., MOORE, T., LAWRENCE, J.M., 3rd, and OSBORN, T. (1994). Cytokine levels in serum and synovial fluid of patients with juvenile rheumatoid arthritis. J. Rheumatol. 21, 2359-2363.
19. LEPORE, L., PENNESI, M., SALETTA, S., PERTICARARI, S., PRESANI, G., and PRODAN, M. (1994). Study of IL-2, IL-6, TNF alpha, IFN gamma and beta in the serum and synovial fluid of patients with juvenile chronic arthritis. Clin. Exp. Rheumatol. 12, 561-565.
20. MANGGE, H., KENZIAN, H., GALLISTL, S., KAULFERSCH, W., BEAUFORT, F., MUNTEAN, W., and SCHAUENSTEIN, K. (1995). Serum cytokines in juvenile rheumatoid arthritis (JRA). Correlation with conventional inflammatory parameters and clinical subtypes. Arthritis Rheum. 38, 211-219.
21. SCHALLER, J. (1984). Chronic arthritis in children. Juvenile rheumatoid arthritis. Clin. Orthop. 182, 79-89.
22. CASSIDY, J., LEVINSON, J., and BASS, J. (1986). A study of classification criteria for diagnosis of juvenile rheumatoid arthritis. Arthritis Rheum. 29, 274-281.
23. BREWER, E., BASS, J., and BAUM, J. (1977). Current proposed revision of JRA criteria. Arthritis Rheum. 20, 195-202.
24. SCHALLER. J. (1983). Pauciarticular arthritis of childhood (pauciarticular juvenile rheumatoid arthritis). Ann. Pediatr. Paris 30, 557-563.
25. COOK, D. (1988). Pauciarticular juvenile arthritis presenting in an adult. J. Rheumatol. 15, 1865-1867.
26. PREVOO. M., VAN RIEL, P., VAN'T HOF, M., VAN RIJSWIJK, M., VAN LEEUWEN, M., KUPER, H., and VAN DE PUTTE, L. (1993). Validity and reliability of joint indices. A longitudinal study in patients with recent onset rheumatoid arthritis. Br. J. Rheumatol. 32, 589-594.
27. MANGGE, H., and SCHAUENSTEIN, K. (1998). Cytokines in juvenile rheumatoid arthritis (JRA). Cytokine 10, 471-480.
28. SILVERMAN, E., LAXER, R., NELSON, D., and RUBIN, L. (1991). Soluble interleukin-2 receptor in juvenile rheumatoid arthritis. J. Rheumatol. 18, 1398-1402.
29. BARRERA, P., HAAGSMA. C., BOERBOOMS, A., VAN RIEL, P., BORM, G., VAN DE PUTTE, L., and VAN DER MEER, J. (1995). Effect of methotrexate alone or in combination with sulphasalzine on the production and circulating concentrations of cytokines and their antagonists. Longitudinal evaluation in patients with rheumatoid arthritis. Br. J. Rheumatol. 34, 747-755.
30. MATSUDA, M., TSUKADA, N., MIYAGI, K., and YANAGISAWA, N. (1994). Increased levels of soluble tumor necrosis factor receptor in patients with multiple sclerosis and HTLV-1-associated myelopathy. J. Neuroimmunol. 52, 33-40.
31. SACK, U., BURKHARDT, U., BORTE, M., SCHADLICH, H., BERG, K., and EMMRICH, F. (1998). Age-dependent levels of select immunological mediators in sera of healthy children. Clin. Diagn. Lab. Immunol. 5, 28-32.
32. 2 shows stable interindividual differences. Scand. J. Immunol. 27, 705-716.
33. WILSON, A., DE VRIES, N., POCIOT, F., DI GIOVINE, F., VAN DER PUTTE, L., and DUFF, G. (1993). An allelic polymorphism within the human tumor necrosis factor α promoter region is strongly associated with HLA Al, B8, and DR3 alleles. J. Exp. Med. 177, 560-577.
34. D'ALFONSO, S., and RICHIARDI, P. (1994). A polymorphic variation in a putative regulation box of the TNFA promoter region. Immungenetics 39, 150-154.